P
Provention Bio
Biotech & Life Sciences · Lebanon, United States · Founded 2016 · IPO 2018
Clinical stage biopharmaceutical dedicated to sourcing, developing and commercializing novel therapeutics MoreLess
Provention Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases. The company operates in the healthcare sector, specifically targeting autoimmune and inflammatory diseases. Provention Bio serves patients who suffer from chronic conditions such as Type 1 Diabetes (T1D), Crohn's Disease, and Systemic Lupus Erythematosus. The company's business model revolves around the research, development, and commercialization of its therapeutic candidates. Revenue is generated primarily through partnerships, licensing agreements, and eventual product sales upon regulatory approval. Provention Bio aims to reduce the high morbidity, mortality, and escalating costs associated with these diseases by intervening before they begin, reappear, or progress. The company is dedicated to transforming treatment paradigms into interception and prevention strategies, thereby improving the quality of life for millions of patients worldwide.
Keywords: biopharmaceuticals, immune-mediated diseases, autoimmune, Type 1 Diabetes, Crohn's Disease, Systemic Lupus Erythematosus, clinical-stage, therapeutics, prevention, healthcare.
Talent graph
Provention Bio's talent
Source: Dealroom Talent Intelligence.
Investors
3 investors on Provention Bio's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Provention Bio has talent and traffic
across markets
Patent intelligence
$4M patent portfolio · 20 active families
Where Provention Bio concentrates vs peers
Each axis is a top-10 topic across Provention Bio and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Provention Bio
An AI-synthesized read of the highest-engagement posts about Provention Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Provention Bio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.